Subjects: CLOZAPINE; SCHIZOPHRENIA treatment; DRUG side effects
تفاصيل العنوان
Subjects: SCHIZOPHRENIA treatment; DRUGS; OLANZAPINEPFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE
Subjects: LETTERS to the editor; SCHIZOPHRENIA treatment
Subjects: Pharmaceutical industry; Public relations; Schizophrenia treatment
Subjects: Drug side effects; Eli Lilly & Co.; Diabetes risk factorsUnited States